Heterogeneity of O-glycosylation in the hinge region of human IgA1

Molecular Immunology

Volumn 37, Issue 17, 2000, Pages 1047-1056

  Novak, Jan ^a,f   Tomana, Milan ^b   Kilian, Mogens ^c   Coward, Lori ^d   Kulhavy, Rose ^a   Barnes, Stephen ^d,e   Mestecky, Jiri ^a,b  

^a University of Alabama at Birmingham   (United States)

^b University of Alabama at Birmingham   (United States)

^c AARHUS UNIVERSITY   (Denmark)

^d UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^e The Purdue Univ Univ of Alabama at Birmingham Botanical Center for Age Related Disease   (United States)

^f Tel: +1 205 9344480   (United States)

Author keywords

Hinge region; IgA1; IgA1 protease; Mass spectrometry; O linked glycans

Indexed keywords

GALACTOSE; GLYCAN DERIVATIVE; GLYCOPEPTIDE; IMMUNOGLOBULIN A1; N ACETYLGALACTOSAMINE; PARAPROTEIN; PROTEINASE;

ARTICLE; CELL HETEROGENEITY; CONTROLLED STUDY; GLYCOSYLATION; HUMAN; MASS SPECTROMETRY; MOLECULAR DYNAMICS; MULTIPLE MYELOMA; PRIORITY JOURNAL;

EID: 0034861890     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(01)00019-0     Document Type: Article

References (88)

1. Remodelling the oligosaccharide of human IgG antibodies: Effect on biological activities
2. Galactosylation of N- and O-linked carbohydrate moieties of IgA1 and IgG in IgA nephropathy
3. Leucocyte β1,3 galactosyltransferase activity in IgA nephropathy
4. Abnormal IgA glycosylation in Henoch-Schoenlein purpura restricted to patients with clinical nephritis
5. O-glycosylation of mesangial IgA1 in IgA nephropathy
6. Impairment of jacalin binding to serum IgA in IgA nephropathy
7. Forth Jenner International glycoimmunology meeting
8. Reduced B cell galactosyltransferase activity in rheumatoid arthritis
9. Structure of the carbohydrate units of IgA1 immunoglobulin II. Structure of the O-glycosidically linked oligosaccharide units
10. Galactose and N-acetylgalactosamine-specific endocytosis of glycopeptides by isolated rat hepatocytes
11. Human hepatic lectin. Physicochemical properties and specificity
12. Glycosylation of immunoglobulin A influences its receptor binding
13. Pathways of O-glycan biosynthesis in cancer cells
14. Elimination of N-linked glycosylation sites from the human IgA1 constant region: Effects on structure and function
15. Genetic remodeling of protein glycosylation in vivo induces autoimmune disease
16. Pathogenesis of IgA nephropathy: Established observations, new insights and perspectives in treatment
17. Glomerulonephritis
18. Agalactosyl IgG in inflammatory bowel disease: Correlation with C-reactive protein
19. IgA glycosylation abnormalities in the serum of patients with primary Sjögren's syndrome
20. Carbohydrate heterogeneity of human IgA myeloma proteins of the IgA1 and IgA2 subclasses
21. O-linked oligosaccharides from human serum immunoglobulin A1
22. Partial duplication in the 'hinge' region of IgA1 myeloma proteins
23. Kinetic study of a galactosyltransferase in the B cells of patients with rheumatoid arthritis
24. β-1,4-Galactosylation of N-glycans is a complex process
25. Down-regulation of Fcα receptors on blood cells of IgA nephropathy patients: Evidence for a negative regulatory role of serum IgA
26. The glycosylation of red cell autoantibodies affects their functional activity in vitro
27. O-linked oligosaccharide on IgA1 hinge region in IgA nephropathy. Fundamental study for precise structure and possible role
28. Analyses of IgA1 hinge glycopeptides in IgA nephropathy by matrix-assisted laser desorption/ionization time-of-flight mass spectrometry
29. Underglycosylation of IgA1 hinge plays a certain role for its glomerular deposition in IgA nephropathy
30. Identification of a carbohydrate-based endothelial ligand for a lymphocyte homing receptor
31. Estimation of the number of O-linked oligosaccharides per heavy chain of human IgA1 by matrix-assisted laser desorption ionization time-of-flight mass spectrometry (MALDI-TOFMS) analysis of the hinge glycopeptide
32. Progress in the pathogenesis of IgA nephropathy
33. Structure of circulating immune complexes (CIC) in IgA nephropathy (IgAN)
34. Microbial evasion of IgA functions
35. IgA1 proteases from Haemophilus influenzae, Streptococcus pneumoniae, Neisseria meningitidis, and Streptococcus sanguis: Comparative immunochemical studies
36. Biological significance of IgA1 proteases in bacterial colonization and pathogenesis: Critical evaluation of experimental evidence
37. Glycosylation changes of IgG associated with rheumatoid arthritis can activate complement via the mannose-binding protein
38. The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fcα receptor interactions
39. Immunoglobulin A (IgA)
40. IgA subclaesses
41. Structural heterogeneity of glycans in immunoglobulin molecules: Implications in IgA nephropathy
42. Defective galactosylation and clearance of IgA1 molecules as a possible etiopathogenic factor in IgA nephropathy
43. Alteration in the IgA carbohydrate chains influence the cellular distribution of IgA1
44. Cellular distribution, regulation, and biochemical nature of an Fcα receptor in humans
45. Dysfunctions of Fcα receptors by blood phagocytic cells in IgA nephropathy
46. Hyperimmunization alters Fcγ antigenicity. Linkage to glycosylation
47. Dual function of human IgA antibodies: Inhibition of phagocytosis in circulating neutrophils and enhancement of responses in IL-8-stimulated cells
48. The role of the carbohydrate chains in complement (C3) fixation by solid phase-bound human IgA
49. Biological significance of carbohydrate chains on monoclonal antibodies
50. IgA nephropathy (IgAN): A similarity in the mechanism of IgA1 deposition in the kidney in humans and mice
51. Direct evidence for decreased sialylation and galactosylation of human serum IgA1 Fc O-glycosylated hinge peptides in IgA nephropathy by mass spectrometry
52. Role of N-linked glycosylation in expression of E-selectin on human endothelial cells
53. + T lymphocyte homeostasis by modulating O-glycan biosynthesis
54. The role of IgG glycoforms in the pathogenesis of rheumatoid arthritis
55. Agalactosyl glycoforms of IgG autoantibodies are pathogenic
56. Glycopeptide profiling of human urinary erythropoietin by matrix-assisted laser desorption/ionization mass spectrometry
57. Molecular aspects of immunoglobulin A1 degradation by oral streptococci
58. The N-glycans determine the differential blood clearance and hepatic uptake of human immunoglobulin (Ig)A1 and IgA2 isotypes
59. Complement-fixing properties of human IgA antibodies. Alternative pathway complement activation by plastic-bound, but not specific antigen-bound, IgA
60. Carbohydrate-deficient glycoprotein syndrome type II
61. Mammalian glycosyltransferases
62. The asialoglycoprotein receptor: Relationship between structure, function and expression
63. Endocytosis of asialoglycoprotein-enzyme conjugates by hepatocytes
64. IgA interactions with the asialoglycoprotein receptor
65. Site-specific characterization of glycoprotein carbohydrates by exoglycosidase digestion and laser desorption mass spectrometry
66. Evidence for a site-specific fucosylation of N-linked oligosaccharide of immunoglobulin A1 from normal human serum
67. Studies of aglycosylated chimeric mouse-human IgG. Role of carbohydrate in the structure and effector functions mediated by the human IgG constant region
68. Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation
69. T cell clones with normal or defective O-galactosylation from a patient with permanent mixed-field polyagglutinability
70. Persistent repression of a functional allele can be responsible for galactosyltransferase deficiency in Tn syndrome
71. Glycoproteins in inflammatory bowel disease
72. The carbohydrate composition of human myeloma IgA
73. The differences in carbohydrate composition between the subclasses of IgA immunoglobulins
74. Gas chromatographic analysis of lens monosaccharides
75. Carbohydrate-mediated clearance of secretory IgA from the circulation
76. Receptor-mediated binding and uptake of immunoglobulin A by human liver
77. Abnormal glycosylation of serum IgG from patients with chronic inflamatory diseases
78. Abnormal galactosylation of serum IgG in patients with systemic lupus erythematosus and members of families with high frequency of autoimmune diseases
79. Occurence of deficient galactosylation of serum IgG prior to the onset of rheumatoid arthritis
80. Galactose-deficient IgA1 in sera of IgA nephropathy patients is present in complexes with IgG
81. Circulating immune complexes in IgA nephropathy consist of IgA1 with galactose-deficient hinge region and antiglycan antibodies
82. IgA1 glycosylation and the pathogenesis of IgA nephropathy
83. Location and structural significance of the oligosaccharides in human IgA1 and IgA2 immunoglobulins
84. Detection of glycosylation abnormality in rheumatoid IgG using N-Acetylglucosamine-specific Psathyrella velutina lectin
85. Biological roles of oligosaccharides: All of the theories are correct
86. Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin
87. Lectin receptors on IgA isotypes
88. Glycosylation of IgA is required for optimal activation of the alternative complement pathway by immune complexes